Shine-on Biomedical Co., Ltd.

This study tests a new drug called SOA101 in people with advanced solid tumors (like lung, ovarian, or breast cancer) who have no other treatment options. The drug is a special antibody designed to help the immune system attack cancer cells. The study aims to find the safest dose…

This early-stage study tests a new drug called SOB100 in 15 healthy adults to see if it is safe and how the body processes it. SOB100 is a tiny particle (exosome) designed to target a specific protein. No treatment benefit is expected; the goal is to gather safety information for…